World Health Organization Sounds Alert Over Severe Shortage of Obesity Medications
Under a tenth of individuals who could benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it publishes its inaugural recommendations on the medications.
Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for increased and just availability to this class of drugs.
Per forecasts, more than two billion will be obese by 2030 without intervention.
"Our latest guidance affirms that excess weight is a long-term condition that can be treated with comprehensive and lifelong support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and logistical bottlenecks are significant hurdles to widespread availability to the treatments that can help people shift considerable weight, says the organization.
Skinny Jab Shortage
Even under the current most optimistic outlook, the manufacturing of these medications might only reach approximately 100 million people – under 10% of the global need, per the health organization.
The advice calls on nations and manufacturers to widen access, by strategies like patent sharing.
A patent on the active ingredient – the core ingredient of the drug Wegovy – is scheduled to end in several nations in 2026.
The Way Obesity Drugs Work
These medications mimick a biological compound to reduce digestion speed, suppress the appetite and boost the sense of being full so people reduce food intake.
People typically begin shedding pounds in the initial weeks of starting on the weekly injections.
Studies indicates people may put most of the weight back on a year later of discontinuing the medication, as their normal appetite return.
To be carrying excess weight increases your chance for contracting health problems, such as type 2 diabetes, heart disease, stroke, and certain malignancies.
Obesity affects individuals in countries worldwide and was linked to millions of fatalities worldwide in 2024, according to the health agency.
